• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Zoetis Inc.

< Previous 1 2 3 4 5 Next >
News headline image
Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
October 29, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Appoints Stephanie Tilenius to its Board of Directors
October 28, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
October 15, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
October 10, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Declares Fourth Quarter 2025 Dividend
October 09, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle
September 30, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results
September 23, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
September 12, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 27, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces Pricing of $1.85 Billion of Senior Notes
August 11, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook
August 05, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Host Webcast and Conference Call on Second Quarter 2025 Financial Results
July 01, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Releases 2024 Sustainability Progress Update
June 05, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Dr. Mark Stetter Elected to Zoetis Board of Directors
May 22, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Declares Third Quarter 2025 Dividend
May 21, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Participate in Upcoming Investor Conferences
May 15, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces First Quarter 2025 Results
May 06, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial Results
March 27, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Participate in Upcoming Investor Conferences
February 20, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
February 14, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Reports Fourth Quarter and Full Year 2024 Results
February 13, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Declares Second Quarter 2025 Dividend
February 06, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain
February 04, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results
January 07, 2025
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase
December 12, 2024
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 19, 2024
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role
November 11, 2024
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis to Participate in Jefferies London Healthcare Conference
November 07, 2024
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Announces Third Quarter 2024 Results
November 04, 2024
From Zoetis Inc.
Via Business Wire
Tickers ZTS
News headline image
Zoetis Declares Fourth Quarter 2024 Dividend
October 10, 2024
From Zoetis Inc.
Via Business Wire
Tickers ZTS
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap